About this trial
This study investigates the effects of a sequential "lying-sitting-standing" Baduanjin intervention on patients with acute coronary syndrome complicated by heart failure. By evaluating cardiopulmonary function and quality of life through indicators such as echocardiography, NT-proBNP, 6MWT, NYHA classification, and SF-36, we aim to compare its efficacy with conventional treatment. The objective is to provide new insights for early cardiac rehabilitation strategies in patients with acute coronary syndrome complicated by heart failure
Eligibility criteria
Qualifiers
Patients meeting the diagnostic criteria for ACS (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction)
Complicated by heart failure during hospitalization
Age ≤ 85 years
Muscle strength ≥ grade 3
Disqualifiers
Patients with persistent heart failure symptoms or NYHA functional class IV despite optimal pharmacological therapy;
Patients with contraindications to cardiac rehabilitation, such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability;
Patients with untreated structural heart disease, such as heart failure caused by valvular heart disease or congenital heart disease;
Patients in the acute phase of various diseases, such as severe infection, deep vein thrombosis, or severe hepatic or renal failure;
Trial design
Treatments tested in this trial
- standard treatment and routine rehabilitation nursing guidance
- "Lying-Sitting-Standing" Sequential Baduanjin
Treatment groups
Sponsors and collaborators
Xiling Qi
Lead sponsor
Second Hospital of Shanxi Medical University
Sponsor institution